TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis

Lu Zhang1, Ji Cao1, Longying Dong2

  • 1Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853.

Insights

This study reveals TiPARP as a key deactivator for oncogenic transcription factors like HIF-1. Activating TiPARP demonstrates significant antitumor effects, suggesting a novel anticancer strategy.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • Transcription factor activity requires precise control, including deactivation.
  • Oncogenic transcription factors like HIF-1 play roles in cancer development.
  • Mechanisms for deactivating transcription factors are not fully understood.

Purpose of the Study:

  • To elucidate the deactivation mechanism of HIF-1 and other oncogenic transcription factors.
  • To investigate the role of TiPARP in transcription factor regulation.
  • To explore the potential of TiPARP as an anticancer therapeutic target.

Main Methods:

  • Investigated the interaction between HIF-1 and TiPARP.
  • Utilized cell culture and mouse xenograft models to assess TiPARP's function.
  • Examined the role of ADP ribosylation in TiPARP-mediated deactivation.

Main Results:

  • HIF-1 promotes the transcription of TiPARP, an ADP ribosyltransferase.
  • TiPARP forms nuclear bodies that recruit HIF-1α and the E3 ubiquitin ligase HUWE1.
  • TiPARP-mediated degradation of HIF-1α, c-Myc, and estrogen receptor was observed.
  • TiPARP demonstrated significant antitumor effects in vitro and in vivo.

Conclusions:

  • TiPARP acts as a negative-feedback regulator for multiple oncogenic transcription factors.
  • Protein ADP-ribosylation plays a role in transcription factor deactivation.
  • Activating TiPARP presents a promising anticancer strategy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
17.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.4K